ImpediMed Ltd - Company Profile
Powered by 
All the sales intelligence you need on ImpediMed Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how ImpediMed Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with ImpediMed Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
ImpediMed Ltd (ImpediMed) develops innovative devices that leverage bioimpedance spectroscopy (BIS) for non-invasive clinical assessment and monitoring of fluid status and tissue composition. The company’s strength lies in its versatile technology portfolio, research and development activities and the advanced applications of its SOZO Digital Health Platform. However, weak operating performance pose a potential concern for its financial sustainability. ImpediMed can benefit from ongoing product innovation, growing market for cancer treatments and the unmet clinical needs in lymphedema. Despite these opportunities, the company faces threats from intense competition, stringent regulatory requirements, and the rapid pace of technological advancements, which could challenge its market position and growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer